MET-233I
A Study of MET233 in Individuals With Obesity or Overweight
Pfizer · Phase 1 · Completed · Enrollment 144
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
MET-233I
Pfizer · Phase 1 · Completed · Enrollment 144
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.